Versus Systems Announces Strategic Investment From Cronus Equity Capital Group, LLC; The Investment Contemplates The Issuance Of Up To 24,727,361 Shares Of Versus To CECG Representing ~51% Of The Co's Issued And Outstanding Shares
Versus Systems Announces Strategic Investment From Cronus Equity Capital Group, LLC; The Investment Contemplates The Issuance Of Up To 24,727,361 Shares Of Versus To CECG Representing ~51% Of The Co's Issued And Outstanding Shares
Versus Systems Inc. ("Versus" or the "Company") (NASDAQ:VS) announced today that the Company recently secured a strategic investment (the "Investment") from Cronus Equity Capital Group, LLC ("CECG").
Versus Systems Inc.（“Versus” 或 “公司”）（納斯達克股票代碼：VS）今天宣佈，該公司最近獲得了Cronus Equity Capital Group, LLC（“CECG”）的戰略投資（“投資”）。
The Investment contemplates the issuance of up to 24,727,361 common shares of Versus to CECG representing approximately 51% of the Company's issued and outstanding common shares of which 15,838,441 common shares (the "First Tranche) were issued to CECG on November 22, 2023 and a further 8,888,920 common shares (the "Second Tranche") are expected to be issued to CECG next week.
該投資計劃向CECG發行多達24,727,361股Versus普通股，約佔公司已發行和流通普通股的51％，其中15,838,441股普通股（“第一批”）已於2023年11月22日向CECG發行，預計下週將再向CECG發行8,888,920股普通股（“第二批”）。
Per the terms of the agreement, CECG purchased the First Tranche at a price of $0.1618 per share, representing a premium to the five-day average Nasdaq Official Closing Price of $0.1578 per share, for a total USD $2,562,659.76. The Second Tranche will be completed at the same price per share.
根據協議條款，CECG以每股0.1618美元的價格收購了第一批股票，高於納斯達克官方每股0.1578美元的五天平均收盤價，總價爲2562,659.76美元。第二批將以相同的每股價格完成。
There were no warrants in the transaction.
交易中沒有認股權證。